trending Market Intelligence /marketintelligence/en/news-insights/trending/-DyEVe95TJ2WK8zPLtJnyA2 content esgSubNav
In This List

Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

Bridgewater, N.J.-based medical technology company Valeritas Holdings Inc. said it attracted a $21 million investment in the company.

Valeritas, which is developing technologies to treat patients with type 2 diabetes in the U.S. and China, said Chicago-based investment firm Aspire Capital Fund LLC agreed to purchase $21 million worth of the company's stock over a 30-month period.

Aspire Capital has already bought 791,557 shares of the company for $1.2 million following the agreement.